46
MEDYA
TR
EN
Home
Genel
News Detail
Morning Star
May 27, 2026
|
20:00
PharmaEssentia Appoints Eric Vogel as U.S. Head of Commercialization Ahead of Potential Launch of BESREMi® in Essential Thrombocythemia
...
Full Story at Source
Related News
Oil Permits Surge In First Q 2026 With Majority For Dangerous Extraction Techniques; Consumer Watchdog Warn New State Drilling Law Unfair
Securities Fraud Investigation Into AECOM (ACM) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
East Coast Wings + Grill to Enter Florida with First Tallahassee Location
Comex Silver Settles 2.24% Lower at $74.599
